Obstructive Sleep Apnoea and Lipid Metabolism: The Summary of Evidence and Future Perspectives in the Pathophysiology of OSA-Associated Dyslipidaemia

Obstructive sleep apnoea (OSA) is associated with cardiovascular and metabolic comorbidities, including hypertension, dyslipidaemia, insulin resistance and atherosclerosis. Strong evidence suggests that OSA is associated with an altered lipid profile including elevated levels of triglyceride-rich li...

Descripción completa

Detalles Bibliográficos
Autores principales: Meszaros, Martina, Bikov, Andras
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687681/
https://www.ncbi.nlm.nih.gov/pubmed/36359273
http://dx.doi.org/10.3390/biomedicines10112754

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687681/
https://www.ncbi.nlm.nih.gov/pubmed/36359273
http://dx.doi.org/10.3390/biomedicines10112754

Ejemplares similares